Indocyanine green dye-enhanced micropulsed diode laser: A novel approach to subthreshold RPE treatment in a case of central serous chorioretinopathy

European Journal of Ophthalmology

Volumn 14, Issue 1, 2004, Pages 74-82

  Ricci, Federico ^a   Missiroli, F ^a   Cerulli, L ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Central serous chorioretinopathy; Dye enhanced photocoagulation; Indocyanine green angiography; Minimum intensity photocoagulation; Optical coherence tomography

Indexed keywords

GLUCOSE; INDOCYANINE GREEN;

ADULT; ARTICLE; CASE REPORT; CENTRAL SEROUS RETINOPATHY; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIODE LASER; DISEASE COURSE; ENERGY; EYE; FLUORESCENCE ANGIOGRAPHY; HUMAN; HYPERMETROPIA; INJECTION; LASER COAGULATION; MALE; NEUROEPITHELIUM; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DETACHMENT; SAFETY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 1542744967     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210401400115     Document Type: Article

References (52)

1. Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. 4th ed. St. Louis: Mosby, 1997: 52-70.
2. Yannuzzi LA. Type-A behaviour and central serous chorioretinopathy. Retina 1987; 7: 111-31.
3. Gass JDM, Slamovits TL, Fuller DW, Gieser RG, Lean JS. Posterior chorioretinopathy and retinal detachment after organ transplantation. Arch Ophthalmol 1992; 110: 1717-22.
4. Cheng LL, Kwok AK, Wat NM, Neoh EL, Jon HC, Lam DS. Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant. Am J Ophthalmol 2002; 134: 293-5.
5. Gass JDM, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology 1995; 102: 737-47.
6. Haimovici R, Gragoudas ES, Duker JS, et al. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology 1997; 104: 1653-60.
7. Eckstein MB, Spalton DJ, Holder G. Visual loss from central serous retinopathy in systemic lupus erythematosus. Br J Ophthalmol 1993; 77: 607-9.
8. Cunningham ET Jr., Alfred PR, Irvine AR. Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology 1996; 103: 2081-90.
9. Bouzas EA, Scott MH, Mastorakos G, et al. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 1993; 111: 1229-33.
10. Tittl MK, Spaide RF, Wong D, Pilotto E, et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999; 128: 63-8.
11. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. I. General concepts and classification. Am J Ophthalmol 1967; 63: 573-85.
12. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol 1967; 63: 587-615.
13. Robertson DM, Ilstrup D. Direct, indirect and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 1983; 95: 457-66.
14. Ficker L, Vafidis G, While A, Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1988; 72: 829-34.
15. Watzke RC, Burton TC, Woolson RF. Direct and indirect laser photocoagulation of central serous choroidopathy. Am J Ophthalmol 1979; 88: 914-8.
16. Shatz H, Yannuzzi LA, Fitter KA. Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: complication or misdiagnosis? Trans Am Acad Ophthalmol Otolaryngol 1977; 83: 893-906.
17. Robertson DM. Argon laser photocoagulation treatment in central serous chorioretinopathy. Ophthalmology 1986; 93: 972-4.
18. Khosla PK, Rana SS, Tewari HK, Azad RU, Talwar D. Evaluation of visual function following argon laser photocoagulation in central serous retinopathy. Ophthalmic Surg Lasers 1997; 28: 693-7.
19. Folk JC and Pulido JS. Miscellaneous chorioretinal disorders. In: Ophthalmology Monographs 11 - Laser photocoagulation of the retina and the choroid. San Francisco: American Academy of Ophthalmology, 1997; 239-240.
20. Friberg TR, Karatza EC. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology 1997; 104: 2030-8.
21. Moorman CM, Hamilton AM. Clinical applications of the MicroPulse diode laser. Eye 1999; 13: 145-50.
22. Stanga PE, Reck AC, Hamilton AM. Micropulse laser in the treatment of diabetic macular edema. Semin Ophthalmol 1999; 14: 210-3.
23. Olk RJ, Friberg TR, Stickney KL, et al. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Ophthalmology 1999; 106: 2082-90.
24. Chang AA, Morse LS, Handa JT, Morales RB et al. Histologic localization of ICG dye in aging primate and human ocular tissues with clinical angiographic correlation. Ophthalmology 1998; 105: 1060-8.
25. Iida T, Hagimura N, Sato T, Kishi S. Evaluation of central serous chorioretinopathy with optical coherence tomography. Am J Ophthalmol 2000; 129: 16-20.
26. Klein ML, Van Buskirk EM, Friedman E, Gragoudas E, Chandra S. Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol 1974; 91: 247-50.
27. Brancato R, Scialdone A, Pece A, Coscas G, Binaghi M. Eight-year follow-up of central serous chorioretinopathy with and without laser treatment. Graefes Arch Clin Exp Ophthalmol 1987; 225: 166-8.
28. Loo RH, Scott IU, Flynn HW Jr, et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina. 2002; 22: 19-24.
29. Framme C, Brinkmann R, Birngruber R, Roider J. Autofluorescence imaging after selective RPE laser treatment in macular diseases and clinical outcome: a pilot study. Br J Ophthalmol 2002; 86: 1099-106.
30. Roider J, Brinkman R, Wirbelauer C, Laqua H et al. Retinal sparing by selective retinal pigment epithelial photocoagulation. Arch Ophthalmol 1999; 117: 1028-34.
31. Mainster MA. Wavelenght selection in macular photocoagulation. Ophthalmology 1986; 93: 952-8.
32. Berger JV. Thermal modelling of micropulsed diode laser retinal photocoagulation. Lasers Surg Med 1997; 20: 409-15.
33. Desmetre T, Deivoselle JM, Mordon S. Fluorescence properties and metabolic features of ICG as related to angiography. Surv Ophthalmol 2000; 45: 15-27.
34. Mainster MA, Reichel E. Transpupillary thermotherapy for age-related macular degeneration: long-pulse photocoagulation, apoptosis, and heat shock proteins. Ophthalmic Surg Lasers 2000; 31: 359-73.
35. Chong LP, Kohen L, Kelsoe W, Donovan M, Buzawa D. Selective RPE damage by micro-pulse diode laser photocoagulation. Invest Ophthalmol Vis Sci 1992; 33 (Suppl): S722.
36. Chong LP, Kohen L. A retinal laser which damages only the RPE: ultrastructural study. Invest Ophthalmol Vis Sci. 1993; 34 (Suppl): S960.
37. Reichel E, Puliafito CA, Duker JS, Guyer DR. Indocyanine green dye enhanced diode laser photocoagulation of poorly defined subfoveal choroidal neovascularization. Ophthalmic Surg 1994; 25: 195-201
38. Obana A, Gohto Y, Nishiguchi K, Miki T, Nishi S, Asada A. A retrospective pilot study of indocyanine green enhanced diode laser photocoagulation for subfoveal choroidal neovascularization Associated with Age-Related Macular Degeneration. Jap J Ophthalmol 2000; 44: 668-76.
39. Flower RW. Experimental studies of indocyanine green dye-enhanced photo-coagulation of choroidal neovascularization feeder vessels. Am J Ophthalmol 2000; 129: 501-12.
40. Puri P, Gupta M, Rundle PA, Rennie IG. Indicyanine green augmented transpupillary thermotherapy in the management of choroidal metastasi from breast carcinoma. Eye 2001; 15: 515-8.
41. Kamal A, Watts A, Rennie IG. Indocyanine green dye enhanced transpupillary thermotherapy of circumscribed choroidal haemangioma. Eye 2000; 14: 701-5.
42. Costa RA, Farah ME, Freymuller E, Morales PH et al. Choriocapillaris Photodynamic Therapy Using Indocianine Green. Am J Ophthalmol 2001; 132: 557-65.
43. Costa RA, Farah ME, Cardillo JA, Belfort R Jr. Photodynamic therapy with indocyanine green for occult subfoveal choroidal neovascularization caused by age-related macular degeneration. Curr Eye Res 2001; 23: 271-5.
44. Costa RA, Scapucin L, Moraes NS, Calucci D, et al. Indocyanine green-mediated photothrombosis as a new technique of treatment for persistent central serous chorioretinopathy. Curr Eye Res 2002; 25: 287-97.
45. Decoste S, Farinelli W, Flotte T, Anderson R. Dye-enhanced laser welding for skin closure. Laser Surg Med 1992; 12: 25-32.
46. Baumler W, Abels C, Karrer S, et al. Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer 1999; 80: 360-3.
47. Abels C, Fickweiler S, Weiderer P, Baumler W, et al. Indocyanine green (ICG) and laser irradiation induce photooxidation. Arch Dermatol Res 2000; 292: 404-11.
48. Spitznas M. Pathogenesis of central serous retinopathy: a new working hypothesis. Graefes Arch Clin Exp Ophthalmol 1986; 224: 321-4.
49. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996; 121: 26-34.
50. Marmor MF. New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol 1988; 226: 548-52.
51. Spitznas M. Central serous retinopathy. In: Ryan SJ, ed. Retina. St. Louis: CV Mosby 1989; 2: 217-27.
52. Negi A, Marmor MF. Healing of photocoagulation lesions affects the rate of subretinal fluid resorption. Ophthalmology 1984; 91: 1678-83.